Geographic Corridors

Cross-border execution where boutiques can’t operate.

Four corridors account for most of the cross-border licensing and M&A volume in life sciences, and each carries its own regulatory translation, IP structuring, and counterparty dynamics. These pages set out what we see in each one and the benchmark that matters most when you price a deal there.

24% of tracked cross-border volume

China-to-West

The corridor that reset deal benchmarks.

Chinese biotech assets being licensed or sold into Western markets. Regulatory translation, IP structuring, and cultural navigation. The geography discount narrowed from 50% to 22% since 2022 — companies anchoring to old benchmarks are leaving tens of millions on the table.

Geography discount: 50% (2022) → 22% (H1 2026)

Read the corridor brief →

28% of tracked cross-border volume

Transatlantic

US, EU, UK, and Israel — the highest-volume cross-border corridor.

European biotech out-licensing into US pharma. Israeli platform asset transactions. UK and Swiss deal corridors. EMA and FDA regulatory translation across jurisdictions. European assets increasingly command near-parity economics with US-originated programs.

Largest cross-border corridor by volume

Read the corridor brief →

24% of tracked cross-border volume

Transpacific

US to China, Korea, and Japan — accelerating deal velocity.

The China-to-West licensing wave reset comp benchmarks across 2023–2026. Korean platform deal acceleration has emerged as a distinct sub-corridor. Japanese mid-pharma in-licensing strategy creates opportunities for US-originated assets seeking Asian market access.

Korean biotech deal volume increased 3x from 2023 to 2025

Read the corridor brief →

6% of tracked cross-border volume

Specialty Cross-Border

Where boutiques can’t deliver and bulge brackets won’t engage.

GCC, LATAM, and multi-jurisdiction deal execution. Regulatory complexity that boutiques lack the capability to navigate and bulge brackets won’t pursue at mid-market transaction sizes. Our defensible niche — the structuring and cultural translation layer that makes these deals close.

Average deal complexity 2x higher than domestic transactions

Read the corridor brief →

Bring us your transaction.

We’ll meet you at peer level — anywhere in the world.

Get in Touch Schedule a Call

Issa Kildani

Managing Partner

info@ambrosiaventures.co